Bezafibrate Plus Berberine in Mixed Dyslipidemia
Effect of Berberine Plus Bezafibrate Administration on the Lipid Profile of Patients With Mixed Dyslipidemia: A Pilot Clinical Trial
Sponsor: University of Guadalajara
Listed as NCT02548832, this PHASE3 trial focuses on Mixed Dyslipidemia and remains completed. Sponsored by University of Guadalajara, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Mar 2023 — Jul 2024 [monthly]
Completed PHASE3
Status: Unknown Status → Completed · Phase: PHASE2 → PHASE3
-
Jan 2021 — Mar 2023 [monthly]
Unknown Status PHASE2
-
Oct 2017 — Jan 2021 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE2
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Guadalajara
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Guadalajara, Mexico